Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Differences in 25-hydroxy vitamin D and vitamin D-binding protein concentrations according to the severity of endometriosis

  • Baek, Jong Chul (Department of Obstetrics and Gynecology, Gyeongsang National University Changwon Hospital) ;
  • Jo, Jae Yoon (Department of Obstetrics and Gynecology, Gyeongsang National University Hospital) ;
  • Lee, Seon Mi (Department of Obstetrics and Gynecology, Gyeongsang National University Hospital) ;
  • Cho, In Ae (Department of Obstetrics and Gynecology, Gyeongsang National University Hospital) ;
  • Shin, Jeong Kyu (Department of Obstetrics and Gynecology, Gyeongsang National University Hospital) ;
  • Lee, Soon Ae (Department of Obstetrics and Gynecology, Gyeongsang National University Hospital) ;
  • Lee, Jong Hak (Department of Obstetrics and Gynecology, Gyeongsang National University Hospital) ;
  • Cho, Min-Chul (Institute of Health Sciences, Gyeongsang National University) ;
  • Choi, Won Jun (Department of Obstetrics and Gynecology, Gyeongsang National University Hospital)
  • Received : 2018.10.21
  • Accepted : 2019.05.10
  • Published : 2019.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To investigate serum 25-hydroxyl vitamin D (25(OH)D) and vitamin D-binding protein (VDBP) concentrations in women with endometriosis according to the severity of disease. Methods: Women with mild endometriosis (n = 9) and advanced endometriosis (n = 7), as well as healthy controls (n = 16), were enrolled in this observational study. Serum total 25(OH)D concentrations were analyzed using the Elecsys vitamin D total kit with the Cobas e602 module. Concentrations of bioavailable and free 25(OH)D were calculated. Concentrations of VDBP were measured using the Human Vitamin D BP Quantikine ELISA kit. Variables were tested for normality and homoscedasticity using the Shapiro-Wilk test and Leven F test, respectively. Correlation analysis was used to identify the variables related to total 25(OH)D and VDBP levels. To assess the effects of total 25(OH)D and VDBP levels in the three groups, multivariate generalized additive modeling (GAM) was performed. Results: Gravidity and parity were significantly different across the three groups. Erythrocyte sedimentation rate (ESR) and CA-125 levels increased as a function of endometriosis severity, respectively (p= 0.051, p= 0.004). The correlation analysis showed that total 25(OH)D levels were positively correlated with gravidity (r = 0.59, p< 0.001) and parity (r = 0.51, p< 0.003). Multivariate GAM showed no significant relationship of total 25(OH)D levels with EMT severity after adjusting for gravidity and ESR. However, the coefficient of total 25(OH)D levels with gravidity was significant (1.87; 95% confidence interval, 0.12-3.63; p= 0.040). Conclusion: These results indicate that vitamin D and VDBP levels were not associated with the severity of endometriosis.

Keywords

References

  1. Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G. Pathogenesis of endometriosis: the role of defective 'immunosurveillance'. Eur J Contracept Reprod Health Care 2007;12:194-202. https://doi.org/10.1080/13625180701387266
  2. Akoum A, Kong J, Metz C, Beaumont MC. Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis. Fertil Steril 2002;77:989-94. https://doi.org/10.1016/S0015-0282(02)03082-0
  3. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(6 Suppl):1678S-1688S. https://doi.org/10.1093/ajcn/80.6.1678S
  4. van Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AM, Cornelissen F, van Leeuwen JP, et al. TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation. Ann Rheum Dis 2012;71:606-12. https://doi.org/10.1136/annrheumdis-2011-200424
  5. Karthaus N, van Spriel AB, Looman MW, Chen S, Spilgies LM, Lieben L, et al. Vitamin D controls murine and human plasmacytoid dendritic cell function. J Invest Dermatol 2014;134:1255-64. https://doi.org/10.1038/jid.2013.501
  6. Krishnan AV, Swami S, Peng L, Wang J, Moreno J, Feldman D. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 2010;151:32-42. https://doi.org/10.1210/en.2009-0855
  7. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M. Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 2014;144 Pt A:132-7. https://doi.org/10.1016/j.jsbmb.2013.09.012
  8. Chun RF. New perspectives on the vitamin D binding protein. Cell Biochem Funct 2012;30:445-56. https://doi.org/10.1002/cbf.2835
  9. Yousefzadeh P, Shapses SA, Wang X. Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions. Int J Endocrinol 2014;2014:981581. https://doi.org/10.1155/2014/981581
  10. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67:817-21. https://doi.org/10.1016/S0015-0282(97)81391-X
  11. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 1986;63:954-9. https://doi.org/10.1210/jcem-63-4-954
  12. Heijboer AC, Blankenstein MA, Kema IP, Buijs MM. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012;58:543-8. https://doi.org/10.1373/clinchem.2011.176545
  13. Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 1993;92:183-8. https://doi.org/10.1007/BF00219689
  14. Song M, Konijeti GG, Yuan C, Ananthakrishnan AN, Ogino S, Fuchs CS, et al. Plasma 25-hydroxyvitamin D, vitamin D binding protein, and risk of colorectal cancer in the nurses' health study. Cancer Prev Res (Phila) 2016;9:664-72. https://doi.org/10.1158/1940-6207.CAPR-16-0053
  15. Muscogiuri G, Altieri B, Annweiler C, Balercia G, Pal HB, Boucher BJ, et al. Vitamin D and chronic diseases: the current state of the art. Arch Toxicol 2017;91:97-107. https://doi.org/10.1007/s00204-016-1804-x
  16. Muscogiuri G, Altieri B, de Angelis C, Palomba S, Pivonello R, Colao A, et al. Shedding new light on female fertility: the role of vitamin D. Rev Endocr Metab Disord 2017;18:273-83. https://doi.org/10.1007/s11154-017-9407-2
  17. Anastasi E, Fuggetta E, De Vito C, Migliara G, Viggiani V, Manganaro L, et al. Low levels of 25-OH vitamin D in women with endometriosis and associated pelvic pain. Clin Chem Lab Med 2017;55:e282-4. https://doi.org/10.1515/cclm-2017-0016
  18. Harris HR, Chavarro JE, Malspeis S, Willett WC, Missmer SA. Dairyfood, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol 2013;177:420-30. https://doi.org/10.1093/aje/kws247
  19. Hartwell D, Rodbro P, Jensen SB, Thomsen K, Christiansen C. Vitamin D metabolites--relation to age, menopause and endometriosis. Scand J Clin Lab Invest 1990;50:115-21. https://doi.org/10.3109/00365519009089142
  20. Somigliana E, Panina-Bordignon P, Murone S, Di Lucia P, Vercellini P, Vigano P. Vitamin D reserve is higher in women with endometriosis. Hum Reprod 2007;22:2273-8. https://doi.org/10.1093/humrep/dem142
  21. Miyashita M, Koga K, Izumi G, Sue F, Makabe T, Taguchi A, et al. Effects of 1,25-dihydroxy vitamin D3 on endometriosis. J Clin Endocrinol Metab 2016;101:2371-9. https://doi.org/10.1210/jc.2016-1515
  22. de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet 2010;376:730-8. https://doi.org/10.1016/S0140-6736(10)60490-4
  23. Shen A, Xu S, Ma Y, Guo H, Li C, Yang C, et al. Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: a metaanalysis. J Int Med Res 2015;43:599-609. https://doi.org/10.1177/0300060515583076
  24. Mgodi NM, Kelly C, Gati B, Greenspan S, Dai JY, Bragg V, et al. Factors associated with bone mineral density in healthy African women. Arch Osteoporos 2015;10:206. https://doi.org/10.1007/s11657-015-0206-7

Cited by

  1. Vitamin D-Binding Protein in Pregnancy and Reproductive Health vol.12, pp.5, 2019, https://doi.org/10.3390/nu12051489
  2. Vitamin D and endometriosis: Is there a correlation with disease severity? vol.47, pp.3, 2019, https://doi.org/10.5653/cerm.2019.03342
  3. Relationship between Cyst Fluid Concentrations of Iron and Severity of Dysmenorrhea in Patients with Ovarian Endometrioma vol.86, pp.1, 2019, https://doi.org/10.1159/000514972
  4. The effect of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis vol.37, pp.7, 2019, https://doi.org/10.1080/09513590.2021.1878138
  5. Assessment of 25(OH)D status in patients with genital endometriosis and clinical efficacy of cholecalciferol in the treatment of the disease vol.70, pp.4, 2019, https://doi.org/10.17816/jowd62883
  6. Bone mineral density at age 7 years does not associate with adherence to vitamin D supplementation guidelines in infancy or vitamin D status in pregnancy and childhood: an Odense Child Cohort study vol.126, pp.10, 2019, https://doi.org/10.1017/s0007114521000301
  7. Serum biomarker panel for the diagnosis of rheumatoid arthritis vol.23, pp.1, 2019, https://doi.org/10.1186/s13075-020-02405-7